Product Information
TRIJARDY XR 5-2.5-1,000 MG TAB is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $5.6589 per EA under NDC 00597039523. Its NADAC has been published 210 times since Jun 22, 2022.
Strength
5; 2.5; 1000 mg/1; mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597039523
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA212614On Market Since
4/23/2020
Pharmacological Classes
Price Statistics
The NADAC for TRIJARDY XR 5-2.5-1,000 MG TAB has been published 210 times since Jun 22, 2022, and over the history we have for it it has declined 38.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6589 per EA |
|---|---|
| All-time high | $10.1459 (Dec 31, 2025) |
| All-time low | $5.6418 (Jan 7, 2026) |
| 52-week high | $10.1459 |
| 52-week low | $5.6418 |
| Median price | $9.6536 |
| Average price | $9.2325 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 210 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRIJARDY XR 5-2.5-1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TRIJARDY XR 5-2.5-1,000 MG TAB, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $5.6589 per EA (NDC 00597039523), effective Jun 24, 2026.
How has the price of TRIJARDY XR 5-2.5-1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for TRIJARDY XR 5-2.5-1,000 MG TAB has declined 38.0%. It has been tracked across 210 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for TRIJARDY XR 5-2.5-1,000 MG TAB?
Since Jun 22, 2022, the NADAC for TRIJARDY XR 5-2.5-1,000 MG TAB has ranged from a low of $5.6418 (Jan 7, 2026) to a high of $10.1459 (Dec 31, 2025), with a median of $9.6536 per EA.
Are there cheaper alternatives to TRIJARDY XR 5-2.5-1,000 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TRIJARDY XR 5-2.5-1,000 MG TAB, but none are currently priced below it.
Who manufactures TRIJARDY XR 5-2.5-1,000 MG TAB?
TRIJARDY XR 5-2.5-1,000 MG TAB (NDC 00597039523) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification